NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
12.72
-0.28 (-2.15%)
At close: Feb 27, 2026, 4:00 PM EST
12.67
-0.05 (-0.39%)
After-hours: Feb 27, 2026, 4:10 PM EST
NextCure Market Cap
NextCure has a market cap or net worth of $44.59 million as of February 27, 2026. Its market cap has increased by 128.66% in one year.
Market Cap
44.59M
Enterprise Value
20.87M
1-Year Change
128.66%
Ranking
Category
Stock Price
$12.72
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $44.59M, a decrease of -89.78%. That is a compound annual growth rate of -28.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 44.59M | -10.36% |
| Dec 31, 2025 | 49.74M | 130.37% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipocine | 52.63M |
| Estrella Immunopharma | 49.60M |
| Kezar Life Sciences | 49.50M |
| OS Therapies | 48.60M |
| Apollomics | 45.07M |
| Impact BioMedical | 44.99M |
| Telomir Pharmaceuticals | 44.35M |
| Sensei Biotherapeutics | 43.32M |